Online Program Home
My Program

Legend:
CC = Vancouver Convention Centre   F = Fairmont Waterfront Vancouver
* = applied session       ! = JSM meeting theme

Activity Details

436 Tue, 7/31/2018, 3:05 PM - 3:50 PM CC-West Hall B
SPEED: Tests, Trials, Biomarkers, and Other Topics in Biometrics — Contributed Poster Presentations
Biometrics Section, Biopharmaceutical Section, ENAR
Chair(s): Paul McNicholas, McMaster University
Oral Presentations for this session.
21: Some T-Tests for N-Of-1 Trials with Serial Correlation
Ji-Ling Tang, University of Arkansas for Medical Sciences; Reid D. Landes, University of Arkansas for Medical Sciences; Anne Holbrook, McMaster University; Mark S Mennemeier, University of Arkansas for Medical Sciences; J. Tyler Floyd, University of Central Arkansas
22: Some T-Tests for N-Of-1 Trials with Serial Correlation: Correction Factors for Trials with Few Observations
Reid D. Landes, University of Arkansas for Medical Sciences; Ji-Ling Tang, University of Arkansas for Medical Sciences; Mark S Mennemeier, University of Arkansas for Medical Sciences; J. Tyler Floyd, University of Central Arkansas; Anne Holbrook, McMaster University
23: Hybrid Cluster-Individual Randomization Allocation
Yi-Fan Chen, University of Illinois at Chicago; Jonathan Yabes, University of Pittsburgh
24: Adjusting a Finite Population Block Kriging Estimator for Imperfect Detection
Matthew Higham
25: Using Logistical Regression to Build a Better Diathesis Model of Dupuytren's Contracture Recurrence
Brian Cohen, ACI Clinical
28: A Two-Stage Method to Analyze Multivariate Cluster Biomarkers in Prediction on a Single Binary Outcome
Xiaoying Yu, University of Texas Medical Branch at Galveston; Wenyaw Chan, University of Texas Health Science Center at Houston; Gracie Vargas, University of Texas Medical Branch at Galveston; Rahul Pal, University of Texas Medical Branch at Galveston
29: An Estimation Method for Enzyme Kinetic Model Parameters Based on Bayesian Approach
Boseung Choi, Korea University; Jae Kyoung Kim, Korea Advanced Institute of Science and Technology; Grzegorz A Rempala, The Ohio State University
30: Statistical Precision of Time-to-Event Endpoint in Single Arm Observational Study Using Monte Carlo Simulation
Meijing Wu, AbbVie; Hongwei Wang, AbbVie Inc; Yabing Mai, AbbVie, Inc; Dajun Tian, Chiltern
31: Multiple Testing Procedure Consideration in Clinical Trials
Rachael Wen, Sanofi
32: Practical Determining the Late Effect Parameter in Fleming-Harrington Test When a Delayed Treatment Effect Is Predicted
Yuichiro Kaneko, Astellas Pharma; Satoshi Morita, Kyoto University
33: Inferring Networks from Personal, Dense, Dynamic Data Clouds of Biological and Quantified-Self Data
Elisa Sheng, Arivale
34: Optimal Testing Configurations for Group Testing
Brianna D. Hitt, University of Nebraska-Lincoln; Christopher R. Bilder, University of Nebraska-Lincoln; Joshua M. Tebbs, University of South Carolina; Christopher S. McMahan, Clemson University
35: Common Risk Difference Test and Interval Estimation of Risk Difference for Stratified Bilateral Correlated Data
Xi Shen, State University of New York At Buffalo; Changxing Ma, State University of New York At Buffalo; Guoliang Tian, Southern University of Science and Technology; Kam Chuen Yuen, The University of Hong Kong
36: Functional Data Analysis in Dose-Adjusted Tacrolimus Trough Concentration Modeling: A New Method to Compare Intrapatient Variance Between Patient Cohorts
Janet Kim, Astellas Pharma Global Development, Inc.; Sam Wilson, Astellas Pharma Global Development, Inc.; Jason J Schwartz, Astellas Pharma Global Development, Inc.
38: Design Considerations When Comparing Control, Treatment, and Treatment Plus in Randomized Trials
Abigail Shoben, Ohio State University